#PYC

PYC Therapeutics share price PYC Therapeutics (ASX:PYC) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows PYC Therapeutics’s share price, chart, tr

4 months ago

PYC Therapeutics ( #PYC ) has released " ADOA Program Initiation of Global Repeat Dose Study " on Tue 21 Oct at 09:16 AEST #today #ClinicalTrials #Australia #media #live

0 0 0 0

5 months ago

Looking forward to #BioForward2025! If you’re attending, we’d love to share how we use MIDD and Biometrics expertise to help #biotech & #pharma partners de-risk development, guide dose and schedule decisions & build confidence across the pipeline. Reach out to book a meeting #PYC

1 0 0 0

5 months ago

Looking forward to a busy September for the @Physiomics team. We’ll be at #BioForward2025 in Oxford (30 Sept) and at Biomarkers & Precision Medicine UK in London (30 Sept–1 Oct), sharing how we help biotech & pharma de-risk drug development and advance #PrecisionMedicine. #PYC

0 0 0 0

PYC Therapeutics share price PYC Therapeutics (ASX:PYC) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows PYC Therapeutics’s share price, chart, tr

5 months ago

PYC Therapeutics ( #PYC ) has released " Correction to Trading Halt Request " on Fri 19 Sep at 10:00 AEST #today #trading #Australia #media #ASX

0 0 0 0

PYC Therapeutics share price PYC Therapeutics (ASX:PYC) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows PYC Therapeutics’s share price, chart, tr

5 months ago

PYC Therapeutics ( #PYC ) has released " Change of Managing Director " on Wed 17 Sep at 08:27 AEST #Australia #media #live #ASX #management

0 0 0 0

6 months ago

We’re heading to Colorado this Oct for #ACoP2025! Our team is looking forward to joining discussions on QSP, PBPK & Model-Informed Drug Development (#MIDD) – and sharing how we use these approaches to help drug developers make smarter, evidence-based decisions. @ISOP1 #PYC

0 0 0 0

6 months ago

We’re in Birmingham for the UK Mathematical Biology Conference! ✨ Excited for talks on tumour modelling, treatment optimisation & how mathematical approaches drive smarter #drugdevelopment – themes that connect closely with the work we do at @Physiomics. #PYC

0 0 0 0

PYC Therapeutics share price PYC Therapeutics (ASX:PYC) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows PYC Therapeutics’s share price, chart, tr

6 months ago

PYC Therapeutics ( #PYC ) has released " PKD Program - Presentation of Safety Data at ANZSN " on Fri 29 Aug at 08:37 AEST #today #UnitedStates #ClinicalTrials #Australia #media

0 0 0 0

7 months ago

We're excited to attend the first UK Mathematical Biology Conference (4–5 Sept, @unibirmingham) 🗨️ Looking forward to discussions on mathematical oncology, optimising cancer treatment & modelling to enhance immunotherapies – all closely aligned with our work at @Physiomics. #PYC

0 0 0 0

PYC Therapeutics share price PYC Therapeutics (ASX:PYC) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows PYC Therapeutics’s share price, chart, tr

7 months ago

PYC Therapeutics ( #PYC ) has released " Quarterly Activities/Appendix 4C Cash Flow Report " on Mon 21 Jul at 08:42 AEST #today #tax #government #UnitedStates #ClinicalTrials

0 0 0 0

7 months ago

📣 We're thrilled to announce that @Physiomics has secured two new contracts with a UK clinical-stage #biopharma company developing immunotherapies for a range of diseases. An exciting step forward as we officially launch our #Biometrics service line! physiomics.co.uk/new-head-of-bi… #PYC

0 0 0 0

7 months ago

📣 We are very excited to announce our expanded partnership with DoseMe and the implementation of our Personalised Dosing Software onto their DoseMeRx platform. Read the full press release 👉 physiomics.co.uk/doseme-dosing-… #PYC #PersonalisedDosing @DoseMeApp

0 0 0 0

7 months ago

📣 We’re excited to share that @Physiomics has exceeded market expectations for FY25. Key highlights include a successful launch of our Biometrics service line, new client diversification, and continued progress in personalised medicine. Read more: physiomics.co.uk/trading-update… #PYC

0 0 0 0

PYC Therapeutics share price PYC Therapeutics (ASX:PYC) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows PYC Therapeutics’s share price, chart, tr

8 months ago

PYC Therapeutics ( #PYC ) has released " Approval to Progress Kidney Disease Trial to Next Stage " on Mon 07 Jul at 08:57 AEST #today #ClinicalTrials #Australia #media #live

0 0 0 0

PYC Therapeutics share price PYC Therapeutics (ASX:PYC) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows PYC Therapeutics’s share price, chart, tr

8 months ago

PYC Therapeutics ( #PYC ) has released " Fourth Drug Program Progressing to Human Trials " on Fri 27 Jun at 09:11 AEST #today #ClinicalTrials #Australia #media #live

0 0 0 0

PYC Therapeutics share price PYC Therapeutics (ASX:PYC) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows PYC Therapeutics’s share price, chart, tr

8 months ago

PYC Therapeutics ( #PYC ) has released " FDA Alignment on Registrational Trial Design RP11 Program " on Mon 23 Jun at 08:57 AEST #Australia #media #live #ASX #Tech

1 0 0 0

9 months ago

How can #MIDD help meet the #FDA’s dose optimisation expectations in #oncology?

In Part 2 of our series with Weatherden, we explore how MIDD supports smarter dosing decisions – from IND to Phase 2 & beyond.

Read the full article 👉physiomics.co.uk/dose-matters-n…

#biotech #pharma #PYC

0 0 0 0

9 months ago

Next stop, Boston! ✈️ @Physiomics’ Hayley Close will be BIO International 2025 from 16–19 June. We’re excited to discuss how our expertise in quantitative pharmacology, MIDD, PK/PD, and QSP helps streamline #drugdevelopment and inform smarter decisions. #BIO2025 @IAmBiotech #PYC

1 0 0 0

PYC Therapeutics share price PYC Therapeutics (ASX:PYC) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows PYC Therapeutics’s share price, chart, tr

9 months ago

PYC Therapeutics ( #PYC ) has released " SRC Approves Dose Escalation in ADOA Clinical Trial " on Wed 11 Jun at 09:17 AEST #today #ClinicalTrials #Australia #media #live

0 0 0 0

9 months ago

We’re heading to BIO International 2025 in Boston (June 16-19)! Hayley Close is excited to discuss how our data-driven approach to #drugdevelopment can streamline smarter decisions across the R&D pipeline. Reach out to book a meeting at #BIO2025! #PYC #Biotech

1 0 0 0

@sharepickers.bsky.social

9 months ago

Day 1 at #ASCPT2025! Mark Davies and Hayley Close are ready to connect with leaders in clinical pharmacology and share how Physiomics' expertise in MIDD, PK/PD, and QSP can optimise drug development. Excited to talk smarter dosing, trial designs, and more! #PYC

0 0 0 0

Justin Waite

9 months ago

7 Microcap Companies Covered, Watch 2 THURSDAY 29TH MAY 2025

[PODCAST] 7 Microcap Companies Covered, Watch 2
audioboom.com/posts/872764...

MACRO
Federal Court Blocks Trump's Sweeping Tariffs

MICRO
BRAEMAR SHIPPING #BMS
CRIMSON TIDE #TIDE
GETECH GROUP #GTC
JOURNEO #JNEO
PHYSIOMICS #PYC
SMARTTECH247 #S247
WATKIN JONES #WJG

0 0 0 0

PYC Therapeutics share price PYC Therapeutics (ASX:PYC) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows PYC Therapeutics’s share price, chart, tr

9 months ago

PYC Therapeutics ( #PYC ) has released " Approval to Escalate Dosing in Kidney Disease Trial " on Mon 26 May at 09:13 AEST #today #ClinicalTrials #Australia #media #live

0 0 0 0

10 months ago

We’re heading to #PAGE2025 in Thessaloniki next month! 🎉 Mark Davies & Lea Sta are looking forward to sharing how our expertise in #PKPD, #MIDD & model-based strategies helps de-risk and optimise #drugdevelopment. Planning to attend? Drop us a message – we’d love to meet. #PYC

0 0 0 0

10 months ago

We’re heading to #ASCPT2025 in Washington DC, 28-30th May! 🌎 As specialists in #PKPD modelling, #QSP and biostatistics, we help pharma and biotech teams make smarter, faster development decisions. Come chat to our team to learn more - reach out to book a meeting! #PYC

0 0 0 0

Discover thousands of collaborative articles on 2500+ skills Discover 100 collaborative articles on domains such as Marketing, Public Administration, and Healthcare. Our expertly curated collection combines AI-generated content with insights and advice from ind...

10 months ago

The #FDA’s final guidance on dose optimisation is reshaping #oncology #drugdevelopment.

Catch up on Part 1 of our latest article with Weatherden, and stay tuned for Part 2 on the role of Model-Informed Drug Development (MIDD).

linkedin.com/pulse/dose-mat…

#PYC #Biotech #Pharma

0 0 0 0

Justin Waite

@sharepickers.bsky.social

10 months ago

13 Co’s Covered, 3 = Watch, 1 = Trading Op, 9 = Ignore Podcast: 13 Co’s Covered, 3 = Watch, 1 = Trading Op, 9 = Ignore

Podcast: 13 Co’s Covered, 3 = Watch, 1 = Trading Op, 9 = Ignore
audioboom.com/posts/871790...

MACRO
Trump hints tariffs on China may drop
Britain increases wind farm incentives funding to $720 million

MICRO
#BELL #BBSN #PYC #SPA #B90 #CRPR #CTA #HERC #NAH #SWG #SNX #TAST #VARE

0 0 0 0

PYC Therapeutics share price PYC Therapeutics (ASX:PYC) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows PYC Therapeutics’s share price, chart, tr

10 months ago

PYC Therapeutics ( #PYC ) has released " Presentation of Clinical Proof of Concept in Lead Program " on Mon 28 Apr at 09:02 AEST #today #ClinicalTrials #Australia #media #live

0 0 0 0